By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Corautus Genetics Inc. 

75 Fifth Street NW, Suite 313

Atlanta  Georgia  30308  U.S.A.
Phone: 404-526-6200 Fax:


SEARCH JOBS








Company News
VIA Pharmaceuticals, Inc. and Corautus Genetics Inc. (VEGF) Complete Merger to Form VIA Pharmaceuticals, Inc. 6/6/2007 1:24:36 PM
Corautus Genetics Inc. (VEGF) Stockholders Approve Merger with VIA Pharmaceuticals, Inc. and Related Proposals 6/5/2007 1:07:28 PM
Corautus Genetics Inc. (VEGF) Receives Nasdaq Additional Deficiency Notice 5/30/2007 1:04:28 PM
VIA Pharmaceuticals, Inc. Names Richard Anderson, Mark Bagnall and David Howard as Director Nominees for Combined Company Following Corautus Genetics Inc. (VEGF) Merger 5/25/2007 3:09:26 AM
Corautus Genetics Inc. (VEGF) And VIA Pharmaceuticals, Inc. Announce Merger Agreement 2/8/2007 11:42:11 AM
Corautus Genetics Inc. (VEGF) Announces Discussions Regarding A Potential Business Combination With A Privately-Held Biotech Company 1/17/2007 12:45:15 PM
Corautus Genetics Inc. (VEGF) Receives Determination Letter From Nasdaq Regarding Continued Listing 12/15/2006 10:11:02 AM
Corautus Genetics Inc. (VEGF) Reports Third Quarter Financial Results 11/14/2006 11:57:33 AM
Corautus Genetics Inc. (VEGF) Announces Redirection Of Focus And Transition Of Officers; No Further Clinical Trials For VEGF-2 11/6/2006 12:46:21 PM
The Day In Review: Genentech, Inc. (DNA) Hits Its Numbers 10/10/2006 5:08:06 PM
12345678
//-->